Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trial.

Fiche publication

Date publication

mai 2026

Journal

Diabetes & metabolism

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno , Dr BOHME Philip

Tous les auteurs :
Hadjadj S, Ragot S, Durocher L, Bigot-Corbel E, Kessler L, Tauveron I, Vidal-Trecan T, Saulnier PJ, Gourdy P, Moret M, Rigalleau V, Borot S, Ducluzeau PH, Ciangura C, Paquot N, Vambergue A, Chevalier N, Carette C, Monier A, Böhme P, Pernfornis A, Verges B, Morcel P, Gautier JF, Halimi JM, Henry P, Marre M, Scheen A, Duclos M, Bosquet L, Cariou B,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42177980

Résumé

While physical activity (PA) is associated in observational studies with cardiovascular and renal protection few interventional studies have assessed its long-term effect on renal outcomes. This study is the first to specifically evaluate the impact of high-intensity PA on the slowing of renal function decline in type 2 diabetes (T2D) patients at high risk for kidney disease.